Next Article in Journal
Nutrition Risk, Resilience and Effects of a Brief Education Intervention among Community-Dwelling Older Adults during the COVID-19 Pandemic in Alberta, Canada
Previous Article in Journal
The Problem of Malnutrition Associated with Major Depressive Disorder from a Sex-Gender Perspective
Previous Article in Special Issue
Diet Quality and Measures of Sarcopenia in Developing Economies: A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 14
Issue 5
10.3390/nu14051108
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence and Predictors of Insufficient Plasma Vitamin C in a Subtropical Region and Its Associations with Risk Factors of Cardiovascular Diseases: A Retrospective Cross-Sectional Study

by
Yao-Tsung Lin
1,2,
Li-Kai Wang
1,2,
Kuo-Chuan Hung
1,2,
Chia-Yu Chang
3,4,
Li-Ching Wu
5,6,
Chung-Han Ho
7 and
Jen-Yin Chen
1,*
1
Department of Anesthesiology, Chi Mei Medical Center, Tainan 71004, Taiwan
2
Department of Hospital and Health Care Administration, Chia Nan University of Pharmacy and Science, Tainan 71710, Taiwan
3
Department of Neurology, Chi Mei Medical Center, Tainan 71004, Taiwan
4
The Center for General Education, Southern Taiwan University of Science and Technology, Tainan 80424, Taiwan
5
Center for Precision Medicine, Chi Mei Medical Center, Tainan 71004, Taiwan
6
Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung 80424, Taiwan
7
Department of Medical Research, Chi Mei Medical Center, Tainan 71004, Taiwan
*
Author to whom correspondence should be addressed.
Nutrients 2022, 14(5), 1108; https://0-doi-org.brum.beds.ac.uk/10.3390/nu14051108
Submission received: 23 January 2022 / Revised: 25 February 2022 / Accepted: 4 March 2022 / Published: 6 March 2022
(This article belongs to the Special Issue Nutritional Assessment and Chronic Disease)
Browse Figures
Versions Notes

Abstract

:
Background: to evaluate the prevalence and predictors of insufficient plasma vitamin C among adults in a subtropical region and its associations with cardiovascular disease risk factors including dyslipidemia and lipid-independent markers, namely homocysteine, high-sensitivity C-reactive protein (hs-CRP) and lipoprotein(a). Methods: Data of this retrospective cross-sectional study were extracted from electronic medical database of a Medical Center. Based on plasma vitamin C status, subjects were split into two groups—subjects with sufficient and insufficient plasma vitamin C levels (<50 µmol/L, ≤8.8 mg/L). Results: Prevalence of insufficient plasma vitamin C in 3899 adults was 39%. Multivariate logistic regression identified male gender, high body mass index, age 20–39, and winter/spring as independent predictors of insufficient vitamin C among all subjects. Greater proportions of subjects with insufficient plasma vitamin C had lower high-density lipoprotein cholesterol levels and elevated levels of triglyceride, homocysteine and hs-CRP (all p < 0.001). There were no differences in total cholesterol, low-density lipoprotein cholesterol and lipoprotein(a) between groups. Conclusions: There was a high prevalence of insufficient plasma vitamin C in the subtropical region, which indicates that insufficient plasma vitamin C remains a public health issue. Further study is needed to confirm these findings and to determine the underlying mechanisms.

Graphical Abstract

1. Introduction

Cardiovascular diseases are the leading cause of death worldwide. However, cardiovascular disease is largely preventable. It is critical to prevent cardiovascular diseases by addressing risk factors which can be modifiable and nonmodifiable. Dyslipidemia, including high triglycerides, elevated levels of low-density lipoprotein cholesterol (LDL-C) and low levels of high-density lipoprotein cholesterol (HDL-C), is an established risk factor for cardiovascular diseases [1]. Hyperhomocysteinemia [2], elevated lipoprotein(a) [3] and high C-reactive protein (CRP) [4] are lipid-independent risk factors for cardiovascular diseases. Interestingly, all of these risk factors for cardiovascular diseases are associated with oxidative stress and may be modified.
Vitamin C, also known as ascorbic acid, is a powerful antioxidant and an essential micronutrient which is required for many physiological and biological functions. However, humans are unable to synthesize vitamin C endogenously due to lack of enzyme gulonolactone oxidase as a result of a mutation occurring approximately 40 million years ago [5]. Vitamin C deficiency leads to hypertriglyceridemia and vitamin C supplementation significantly lowers plasma triglyceride levels in guinea pigs [6,7]. LDL-C oxidation increases its atherogenesis in the intima of blood vessels [8]. HDL-C has important cardioprotective effects by the protection of LDL-C from oxidative modification and the reverse cholesterol transport [9]. Although HDL-C has antiatherogenic properties, HDL-C is susceptible to oxidation, which reduces its ability to protecting LDL-C from oxidative modification [10]. Importantly, vitamin C can protect HDL-C and LDL-C from oxidation [11,12,13]. Hence, vitamin C deficiency may increase the risk of dyslipidemia and atherosclerotic development. Among the vast biological functions of vitamin C, it is suggested to play a role in primary prevention of cardiovascular diseases.
Hyperhomocysteinemia has been identified as a strong lipid-independent risk factor for atherosclerotic vascular disease [14]. Homocysteine not only reduces the HDL-C production but also promotes LDL-C oxidation [12,15,16]. As a strong antioxidant, plasma vitamin C levels was found to be negatively associated with homocysteine levels [17]. Elevated lipoprotein(a) is also a lipid-independent risk factor for cardiovascular diseases through stimulation of platelet aggregation and promotion of endothelial dysfunction and phospholipid oxidation [3]. In a transgenic mice model, vitamin C deficiency was found to increase serum lipoprotein(a) levels and promote vascular accumulations of lipoprotein(a) resulting in atherosclerotic changes [18]. CRP, a biomarker of inflammation, is a mediator of atherosclerosis [4]. Supplementation of vitamin C decreases elevated CRP [19]. Taken together, plasma vitamin C levels may have implications for these risk factors of cardiovascular diseases through the interaction and modification. Thus, a whole survey on the correlations between plasma vitamin C and the lipid-related and lipid-independent markers was needed.
A recent review shows that insufficient vitamin C remains common and an important factor in the global burden of diseases [20]. The geographic factor is one of key factors for vitamin C levels. Reports on the prevalence and predictors of insufficient plasma vitamin C of healthy subjects in subtropical regions are limited. The primary aim of the current study was to assess the prevalence and predictors of insufficient plasma vitamin C levels on adults aged 20 and older in a subtropical region. Secondary outcomes were to examine how plasma vitamin C status of the study population may be related to the aforementioned lipid-related and lipid-independent risk factors of cardiovascular diseases.

2. Materials and Methods

This retrospective cross-sectional study was approved by the Institutional Review Board of the Chi Mei Medical Center, a 1200-bed tertiary referral hospital in Tainan, Taiwan, which is located in a subtropical region and is known as ‘‘a fruit kingdom’’ [21]. The study was conducted in accordance with the Declaration of Helsinki.

2.1. Study Population

The periodic health examination in adults is an insured service of Taiwan national health insurance which provides universal, mandatory coverage with a rate up to 99% of Taiwan’s entire population by the end of 2004 [22]. Chi Mei Medical Center provides integrative medical healthcare options [23,24] involving nutrition surveys on serum/plasma vitamins A, B, C, D, E and trace minerals which are not insured. Data of subjects undergoing health examinations at our hospital were routinely stored in the electronic database of the institute. Health examination data at Chi Mei Medical Center between 1 January 2018 and 31 December 2019 were retrospectively collected and analyzed. Inclusion criteria for the current study were: (1) adult subjects aged 20 and older; (2) those with available data of plasma vitamin C, serum homocysteine, high-sensitivity CRP (hs-CRP), lipoprotein(a), triglyceride, total cholesterol, LDL-C and HDL-C examinations during the study period.
Exclusion criteria were: (1) subjects with diabetes or prediabetes (International Classification of Diseases, ICD) (ICD-9 250; ICD-10 E10-E14; R73.09 or HbA1C ≥ 5.7% [25,26]) which are confounders in the relationship of dyslipidemia and vitamin C status [27]; (2) individuals who had diagnostic codes of human immunodeficiency virus infection (HIV) [28] (ICD-9 042, 043, 044; ICD-10 B20-B24), solid organ transplantation [29] (ICD-9 3751, 1160, 1164, 1169, 5059, 5280, 5283, 5569, 3350–3352; ICD-10 Z94), chronic liver diseases (ICD-9 571; ICD-10 K70-77) [30] and/or chronic renal failure (ICD-9 585.5, 585.6; ICD-10 N18.5, N18.6) [31], which are potential confounding factors in the relationship of dyslipidemia and vitamin C status; (3) adults whose medical records showed no evidence of plasma vitamin C and other targeted examinations during the study period. Taiwan began using ICD-10-CM as the replacement for ICD-9-CM in 2016. In our hospital, an autosearch for the target diseases can be conducted by ICD-10 codes or ICD-9 codes which are automatically converted to ICD-10 codes.
Before health examinations, all subjects were required to fill in self-reported questionnaires which were used to collect data including job types, personal habits (smoking, drinking, and sleeping hours), and other items. However, completing the survey questionnaires was voluntary.

2.2. Study Parameters, Definitions and Cutoffs

In current international and national recommendations, a fasting plasma vitamin C concentration below 50 µmol/L (8.8 mg/L) is an indicator of insufficient levels [32]. Five categories of plasma vitamin C were defined: deficiency (≤2.0 mg/L, 11.4 μmol/L); subdeficiency (2.1–6.0 mg/L, 11.4–34.2 μmol/L); suboptimal (6.1–8.8 mg/L, 34.3–49 µmol/L); optimal (8.9–15 mg/L, 50–85 µmol/L); and supraphysiological (>15 mg/L, 85 µmol/L) [33,34,35]. Insufficient levels for vitamin C include deficiency, subdeficiency and suboptimal levels of vitamin C. Sufficient levels for vitamin C include optimal and supraphysiological levels.
The associations between plasma vitamin C concentrations and gender/age/season/body mass index (BMI) in the study population were investigated.
To evaluate the influence of age on plasma vitamin C concentrations, all eligible subjects were divided into three age groups: 20–39, 40–59 and ≥60 [35]. In Taiwan, seasonal fruits in winter are oranges and apples, with 41.2 mg and 2.9 mg of vitamin C per 100 g, respectively. Seasonal fruits in spring are pineapples and bananas, with 12.0 mg and 10.7 mg of vitamin C per 100 g, respectively. The summer fruits are lychees, mangos, pears and grapes with 52.3 mg, 22.7 mg, 4.6 mg and 3.8 mg vitamin C per 100 g, respectively. The autumn fruits are guavas, papayas, pomelos and pitayas with 137.9 mg, 58.3 mg, 54.5 mg and 5.3–6.3 mg vitamin C per 100 g, respectively (https://consumer.fda.gov.tw). The problem of insufficient plasma vitamin C concentration may be diet-based. According to vitamin C amount per 100 g in seasonal fruits, the seasons were categorized into two groups—higher vitamin C amounts in seasonal fruits (i.e., summer and autumn) and lower vitamin C amounts in seasonal fruits (i.e., winter and spring) to examine the association between seasons and plasma vitamin C concentrations. BMI was calculated as the weight in kilograms divided by the square of height in meters (kg/m2). Based on the WHO Asian BMI categories, all subjects in the present study were divided into those who were obese (i.e., BMI ≥ 27.5), overweight (23 ≤ BMI ≤ 27.4) and normal (BMI < 23) [36] to assess the relationship of BMI and plasma vitamin C status.
The ideal triglycerides, total cholesterol and LDL-C levels for an adult are 150 mg/dL, 200 mg/dL and 100 mg/ dL or less, respectively. The optimal cutoff value for HDL-C in predicting the risk of cardiovascular diseases is considered to be 46 mg/dL in the Taiwanese population [37]. The recommended homocysteine level is less than 10 µmol/L [38]. The lipoprotein(a) level (≥30 mg/dL) and hs-CRP (> or =1.0 mg/L) indicate elevated cardiovascular risk [19,39].

2.3. Assessment of Plasma Vitamin C, Serum Homocysteine, hs-CRP, Lipoprotein(a) and Lipid Profiles

2.3.1. Blood Collection and Determination of Plasma Vitamin C Concentrations

A fasting blood sample of each subject was drawn in the morning during the day of the participants’ stay in hospital. The plasma sample after centrifugation was stored at a temperature of −80 °C, because the examination of the plasma vitamin C levels was done not all at once but after the date of hospital stay. Using a chromatograph Acquity UPLC Waters® [40], plasma vitamin C quantification was usually performed once a week.

2.3.2. Blood Collection and Determination of Serum Homocysteine

A fasting blood sample of each subject was drawn and stored at 2–8 °C after centrifugation. Serum levels of total L-homocysteine was determined by using chemiluminescent microparticle immunoassay technology on the ABBOTT Architect i2000SR System [41]. The measurement of homocysteine was completed within 4 h after blood sampling.

2.3.3. Blood Collection and Determination of Serum hs-CRP, Lipoprotein(a) and Lipid Profiles

After an overnight fast, the blood samples of the subjects to measure the levels of hs-CRP, lipoprotein(a), triglyceride, total cholesterol, LDL-C and HDL-C were collected in the morning. The measurement of hs-CRP, lipoprotein(a), triglyceride, total cholesterol, LDL-C and HDL-C was completed within 4 h after the blood collection. Serum levels of hs-CRP were measured by immunoturbidimetric method (Abbott, Architect C-16000 analyzer) [42]. Our laboratory use Denka reagent kits and Denka kits to detect lipoprotein(a) in serum by Turbidimetric Immunology technology on the ABBOTT ARCHITECT c16000 analyzer. [43]. Serum levels of triglycerides, total cholesterol, HDL-C and LDL-C were determined enzymatically using an Abbott Architect c16000 clinical autoanalyzer.

2.4. Statistical Analysis

Data processing and statistical analysis were performed using SAS statistical software (Version 9.4; SAS Institute, Cary, NC, USA). Based on plasma vitamin C status, all subjects were grouped into two groups—subjects with sufficient and insufficient plasma vitamin C levels (<50 µmol/L, ≤8.8 mg/L). The difference of continuous data between groups was conducted by Student t test. Chi-square test was used to determine the significance of differences in categorical variables among groups.
Univariate logistic regression analysis was used to identify predictors of insufficient vitamin C. Confounding factors including gender, age groups, and seasons were adjusted to evaluate the odds ratio in different models. Identified variables that were associated with insufficient vitamin C (p < 0.10) in univariate analyses were entered into a multivariate logistic regression analysis. Independent predictors of insufficient vitamin C were presented as adjusted odds ratios (OR) and 95% confidence intervals (CI). A two-sided p value < 0.05 was significant.

3. Results

3.1. Demographic and Anthropometric Characteristics of the Study Population

After application of the inclusion and exclusion criteria, a total of 3899 subjects were included in the analysis. Demographic and anthropometric characteristics of the study population according to plasma vitamin C status are shown in Table 1.
The results demonstrated 39% of all subjects had insufficient plasma vitamin C levels (<50 µmol/L, ≤8.8 mg/L). Participants with insufficient plasma vitamin C levels were younger (47.6 years (SD 11.8 years), p < 0.001) and had higher BMI (24.90 (SD 3.86), p < 0.001). The prevalence of insufficient plasma vitamin C was higher in males (68.7%, p < 0.001). The proportions of subjects with insufficient plasma vitamin C were significantly different among three age groups (p = 0.001). The percentages of subjects with insufficient plasma vitamin C in four seasons were listed from high to low as spring (43.8%), winter (41.3%), summer (37.3%) and autumn (34.7%), which seemed to be associated with vitamin C amounts per 100 mg in seasonal fruits. As for adiposity, adults with greater BMI had a decreased tendency in plasma vitamin C status (p < 0.001).

3.2. Primary Outcomes

3.2.1. Prevalence of Insufficient Plasma Vitamin C among Adults

According to five categories of plasma vitamin C, more than half of the participants had sufficient plasma vitamin C levels (≥50 µmol/L, ≥8.9 mg/L), composed of 56.0% with optimal and 5.1% with supraphysiological plasma vitamin C levels (i.e., vitamin C ≥ 15.1 mg/L). Insufficient levels of plasma vitamin C (<50 µmol/L, ≤8.8 mg/L) was found in 39% (1520) of the subjects, with deficient (≤2.0 mg/L), subdeficient (2.1–6.0 mg/L) and suboptimal (6.1–8.8 ng/mL) being noted in 1.0% (40), 9.8% (383) and 28.1% (1097) of the study population, respectively (Figure 1a).
Subjects with sufficient plasma vitamin C (≥8.9 mg/L) was more common in females than in males (72.2% vs. 52.2%, respectively, p < 0.001). This indicates that males had a dominant tendency of having insufficient plasma vitamin C (47.8% in males and 27.8% in females, p < 0.001) (Figure 1b).

3.2.2. Predictors for Insufficient Vitamin C Levels among All Subjects

The correlations between the risks of insufficient plasma vitamin C status and demographic/environmental/anthropometric factors (i.e., gender, age, season, and BMI) in 3899 adults are presented in Table 2. Univariate logistic regression revealed a male predominance of insufficient vitamin C (crude OR: 2.37, 95% CI: 2.07–2.71). There was a trend of increasing prevalence of insufficient vitamin C with decreasing ages with the prevalence lowest (35.5%) in the elderly age group (≥60) and highest (44.1%) in the youngest age group (20–39). With reference to that of the ≥60 age group, only the crude OR of insufficient vitamin C for the 20–39 age groups was significantly higher (1.44, 95% CI: 1.18–1.75). There was also a significant seasonal variation in insufficient vitamin C levels with an increased risk in winter/spring compared to that in summer/autumn (crude OR 1.31, 95% CI: 1.16–1.50). In addition, a significant association was also found between BMI and insufficient vitamin C that higher BMI with higher insufficient vitamin C prevalence. The crude OR were 2.78 (95% CI: 2.30–3.35) in the obesity group (BMI ≥ 27.5) and 1.61 (95% CI: 1.39–1.86) in the overweight group (BMI: 23–27.4), respectively. According to the adjusted OR in multivariate logistic regression analysis, the risk factors for insufficient vitamin C were listed from high to low as male gender, high BMI (obesity and overweight), age 20–39, and winter/spring as significant predictors of insufficient vitamin C for all subjects in subtropical Taiwan.

3.2.3. Predictors of Insufficient Vitamin C Levels among Female and Male Subjects

Subgroup analysis by genders, the findings in the female group were similar to that in all subjects (Table 2). Multivariate logistic regression analysis identified the significant predictors for insufficient vitamin C as high BMI (adjusted OR 2.96 for obesity, 1.42 for overweight), 20–39 age group (adjusted OR 2.21) and winter/spring (Adjusted OR 1.47) (Table 3a).
The findings in the male group were slightly different compared to the female group. Multivariate logistic regression revealed that obesity (BMI ≥ 27.5) was statistically significant with adjusted OR: 1.85 (95% CI: 1.44–2.37, p < 0.001), but overweight (BMI 23–27.4) was not with adjusted OR: 1.21 (95% CI: 0.98–1.48, p = 0.073). Winter/spring and the young age group (20–39) were still the risk factors (adjusted OR 1.33 (95% CI: 1.12–1.57); adjusted OR 1.31, 95% CI: (1.01–1.71), respectively) (Table 3b).

3.3. Secondary Outcomes

Comparison of lipid-related and lipid-independent risk factors for cardiovascular diseases in subjects with sufficient and insufficient vitamin C status
Among lipid-related markers, adults with insufficient plasma vitamin C had significantly higher proportion of elevated triglyceride (>150 mg/dL) and low HDL-C (<46 mg/dL). However, there was no difference in total cholesterol and LDL-C between groups. As for lipid-independent markers, there were greater proportions of adults with insufficient plasma vitamin C to have high homocysteine (>10 umol/L) and elevated hs-CRP (≥1 mg/dL) (both p < 0.001). However, no difference in lipoprotein(a) was noted between groups. (Table 4)

4. Discussion

Plasma vitamin C concentrations essentially depend on dietary vitamin C intake, intestinal absorption and renal excretion as well as diseases [27]. The strength of the current study was to provide plasma vitamin C information in adults receiving health examinations and not having diabetes/prediabetes and other chronic diseases (i.e., HIV infection, solid organ transplantation, chronic liver diseases and/or chronic renal failure). We discovered a high prevalence (39%) of insufficient plasma vitamin C in Taiwanese adults, despite the fact that Taiwan is a fruit kingdom [21] and the gross domestic product per capita in Taiwan was USD 22,000–25,000 in the study period (2018–2019). Our results confirm the literature findings that insufficient plasma vitamin C levels remain a current public health issue in many countries including Russia, America, New Zealand and Japan [35,44,45,46]. The cause for the high prevalence of vitamin C insufficiency may be due to unmet recommended dietary intakes in Taiwanese adults. A report based on 24 h dietary recall data from the Nutrition and Health Survey in Taiwan 2005–8 [47] showed that only 20% participants had the recommended number of servings for fruit and approximately 30% met that for vegetables from the Taiwan Food-Guide recommendations for adults [47]. Supplementation may be suggested for patients with insufficient plasma vitamin C.
Multivariate logistic regression analysis identified male gender, high BMI, age 20–39, and winter/spring as independent predictors of insufficient plasma vitamin C for all subjects in subtropical Taiwan. Epidemiological studies have frequently shown higher vitamin C concentrations in females than in males [48]. It may be attributed to more intakes of fruits and vegetables by females [49] as well as partly caused by a volumetric dilution effect due to differences in fat-free mass [50]. Among the health examiners, the young group (20–39 years of age) had lower levels of plasma vitamin C than the older group in this study. This was similar to the result of 2003–2004 National Health and Nutrition Examination Survey in the United States [48] showing that the young group (20–39 years of age) had the lower levels of vitamin C among supplement users [48]. It is likely that older subjects (>60 years of age) paid more attention to their health condition and used the supplements. Although gender and age are nonmodifiable factors, our findings suggest a need for public health interventions to decrease the prevalence of plasma vitamin C insufficiency in the male and young Taiwanese populations and to potentially decrease the risk of long-term adverse health effects.
Major food sources of vitamin C are fresh fruits and vegetables, in particular fresh fruits. Taiwan, located in a subtropical region, is a fruit kingdom, due to the suitable weather that is allows many kinds of fruits to be harvested during all four seasons [21]. In the present study, the highest prevalence (43.8%) of insufficient plasma vitamin C was observed in spring, followed by winter (41.3%), summer (37.3%) and autumn (34.7%). The results seemed to be associated with vitamin C amounts per 100 mg in seasonal fruits. The plasma vitamin C status may vary as a reflection of seasonal change in consumption of overall and particular fruits which depends on the availability and pricing [51]. It is rational that winter/spring independently predicted plasma vitamin C insufficiency due to lower vitamin C amounts in seasonal fruits. Given the higher risk of plasma vitamin C insufficiency in winter/spring, higher dietary vitamin C intakes or vitamin C supplements are required to ensure a sufficient vitamin C supply.
As for the implication of adiposity, high BMI (obesity and overweight) was identified as an independent predictor of insufficient plasma vitamin C among all subjects. Subgroup analysis by gender showed that both obesity and overweight females exhibited greater risk of having insufficient plasma vitamin C compared to females with normal BMI. In males, only obesity (BMI ≥ 27.5) not overweight (BMI 23–27.4) independently predicted for insufficient plasma vitamin C. The findings support previous results that plasma vitamin C was inversely related to BMI [50]. Effects of adiposity on plasma vitamin C were weaker in males due their lower percentage of body fat. Taken together, low consumption of vegetables and fruit as well as obesity were modifiable factors which should be intervened in to receive the benefits of sufficient plasma vitamin C.
In the current study, subjects with insufficient vitamin C status were found to have higher proportions of high triglyceride and low HDL-C significantly when compared to subjects with sufficient plasma vitamin C. However, there was no difference in total cholesterol and LDL-C between groups. Inconsistent with our findings, a previous study demonstrated that plasma levels of ascorbic acid in healthy elderly adults were not correlated with triglycerides, total cholesterol, LDL-C, and HDL-C [52]. However, a meta-analysis of randomized controlled trials shows that vitamin C supplementation with 500 mg daily for a minimum of 4 weeks significantly decreased plasma levels of triglycerides and LDL-C, but had no effective increase on HDL-C [53]. Results are inconsistent among previous studies and ours in examining plasma vitamin C concentrations and levels of dyslipidemia. Obviously, more studies are needed to elucidate the associations between levels of plasma vitamin C and dyslipidemia.
Hyperhomocysteinemia and elevated hs-CRP are well-known lipid-independent risk factors of cardiovascular diseases through increased oxidative stress [12,15,16] which can be reduced effectively by antioxidant effects of vitamin C [13]. In this study, adults with insufficient plasma vitamin C were found to have higher incidence of homocysteine > 10 umol/L and hs-CRP ≥ 1 mg/dL. Results not only support negative correlations between plasma vitamin C and levels of homocysteine/hs-CRP in clinical studies [17,54], but also provided the biomedical evidence for a long-term prospective cohort study showing a negative relationship between plasma vitamin C levels and heart disease mortality [55]. Although lipoprotein(a) was also a lipid-independent risk factor of cardiovascular diseases [3], we found no association between lipoprotein(a) and plasma vitamin C in contrast to a previous study discovering a negative correlation between lipoprotein(a) deposits in brain vessels and brain levels of vitamin C [56]. However, an intervention study revealed no significant lowering effect of vitamin C supplementation 4.5 g/day for 12 weeks on lipoprotein(a) levels in patients with coronary diseases [57]. Accordingly, more studies are needed to investigate the adverse effects of insufficient plasma vitamin C on these lipid-independent risk factors for cardiovascular diseases.
There were some limitations in the current study. First, we did not include data on vitamin C supplement and dietary intake from Food Frequency Questionnaire due to original data lacking this information. However, plasma vitamin C is a more precise index than data on vitamin C supplement and dietary intake for assessing the vitamin C status in human body [58]. Second, despite risk factors of vitamin C deficiency including smoking/alcohol use, we did not evaluate associations between smoking/alcohol use and vitamin C status [50]. Subjects undergoing health examinations were asked to complete a self-reported questionnaire concerning smoking and alcohol use. However, questionnaire completion was voluntary and many subjects chose not to answer these questions. Third, vitamin C status varies by race. Only Taiwanese were included in the study population. Further studies including various races are needed to confirm the findings.

5. Conclusions

A high prevalence of insufficient plasma vitamin C concentrations was found in adult subjects living in a subtropical region. Male gender, high BMI, age 20–39 and winter/spring independently predicted insufficient vitamin C for all subjects. The findings suggest there is a need for public health interventions to decrease the prevalence of plasma vitamin C insufficiency in the high-risk subjects. Future research has to be concerned about public health action plans for potentially reducing the higher rate of insufficient plasma vitamin C concentrations in winter/spring. Significantly greater proportions of subjects with insufficient plasma vitamin C had lower HDL-C levels and high levels of triglyceride, homocysteine and hs-CRP. However, there were no differences in total cholesterol, LDC-C and lipoprotein(a) levels between groups. Future studies are warranted to confirm the findings and to determine the underlying mechanisms of the causal links between plasma vitamin C status and these risk factors of cardiovascular diseases.

Author Contributions

Conceptualization, Y.-T.L., L.-K.W., K.-C.H., C.-Y.C., L.-C.W. and J.-Y.C.; data curation, Y.-T.L., L.-K.W., K.-C.H. and J.-Y.C.; formal analysis, Y.-T.L., L.-K.W., K.-C.H., L.-C.W. and C.-H.H.; funding acquisition, J.-Y.C.; investigation, Y.-T.L., L.-K.W., C.-Y.C., C.-H.H. and J.-Y.C.; methodology, Y.-T.L., L.-K.W., K.-C.H., L.-C.W., C.-H.H. and J.-Y.C.; project administration, J.-Y.C.; resources, J.-Y.C.; software, K.-C.H. and C.-H.H.; supervision, J.-Y.C.; validation, Y.-T.L., C.-Y.C. and J.-Y.C.; visualization, C.-Y.C. and J.-Y.C.; writing—original draft, Y.-T.L., L.-K.W. and J.-Y.C.; writing—review and editing, Y.-T.L., L.-K.W. and J.-Y.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Chi Mei Medical Center, Tainan, Taiwan, grant number CMFHR 11003. The APC was funded by CMFHR 11003.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of the Chi Mei Medical Center, Tainan, Taiwan (IRB-11010-004 and date of approval: 13 October 2021).

Informed Consent Statement

Patient consent was waived due to the retrospective cross-sectional nature of the study.

Data Availability Statement

Anonymized data not published within this article will be made available and shared by request from any qualified investigator.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Wong, M.C.; Zhang, D.X.; Wang, H.H. Rapid emergence of atherosclerosis in Asia: A systematic review of coronary atherosclerotic heart disease epidemiology and implications for prevention and control strategies. Curr. Opin. Lipidol. 2015, 26, 257–269. [Google Scholar] [CrossRef] [PubMed]
  2. Kumar, A.; Palfrey, H.A.; Pathak, R.; Kadowitz, P.J.; Gettys, T.W.; Murthy, S.N. The metabolism and significance of homocysteine in nutrition and health. Nutr. Metab. 2017, 14, 78. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Bucci, M.; Tana, C.; Giamberardino, M.; Cipollone, F. Lp(a) and cardiovascular risk: Investigating the hidden side of the moon. Nutr. Metab. Cardiovasc. Dis. 2016, 26, 980–986. [Google Scholar] [CrossRef]
  4. Abramson, J.L.; Hooper, W.C.; Jones, D.P.; Ashfaq, S.; Rhodes, S.D.; Weintraub, W.S.; Harrison, D.G.; Quyyumi, A.A.; Vaccarino, V. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis 2005, 178, 115–121. [Google Scholar] [CrossRef]
  5. Nishikimi, M.; Fukuyama, R.; Minoshima, S.; Shimizu, N.; Yagi, K. Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man. J. Biol. Chem. 1994, 269, 13685–13688. [Google Scholar] [CrossRef]
  6. Otsuka, M.; Matsuzawa, M.; Ha, T.Y.; Arakawa, N. Contribution of a high dose of L-ascorbic acid to carnitine synthesis in guinea pigs fed high-fat diets. J. Nutr. Sci. Vitaminol. 1999, 45, 163–171. [Google Scholar] [CrossRef]
  7. Fernandez, M.L. Guinea pigs as models for cholesterol and lipoprotein metabolism. J. Nutr. 2001, 131, 10–20. [Google Scholar] [CrossRef] [Green Version]
  8. Westhuyzen, J. The oxidation hypothesis of atherosclerosis: An update. Ann. Clin. Lab. Sci. 1997, 27, 1–10. [Google Scholar]
  9. Nofer, J.R.; Kehrel, B.; Fobker, M.; Levkau, B.; Assmann, G.; von Eckardstein, A. HDL and arteriosclerosis: Beyond reverse cholesterol transport. Atherosclerosis 2002, 161, 1–16. [Google Scholar] [CrossRef]
  10. Witztum, J.L. The oxidation hypothesis of atherosclerosis. Lancet 1994, 344, 793–795. [Google Scholar] [CrossRef]
  11. Freyschuss, A.; Xiu, R.-J.; Zhang, J.; Ying, X.; Diczfalusy, U.; Jogestrand, T.; Henriksson, P.; Björkhem, I. Vitamin C reduces cholesterol-induced microcirculatory changes in rabbits. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 1178–1184. [Google Scholar] [CrossRef] [PubMed]
  12. Hillstrom, R.J.; Yacapin-Ammons, A.K.; Lynch, S.M. Vitamin C inhibits lipid oxidation in human HDL. J. Nutr. 2003, 133, 3047–3051. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Alul, R.H.; Wood, M.; Longo, J.; Marcotte, A.L.; Campione, A.L.; Moore, M.K.; Lynch, S.M. Vitamin C protects low-density lipoprotein from homocysteine-mediated oxidation. Free Radic. Biol. Med. 2003, 34, 881–891. [Google Scholar] [CrossRef]
  14. Hackam, D.G.; Anand, S.S. Emerging risk factors for atherosclerotic vascular disease: A critical review of the evidence. JAMA 2003, 290, 932–940. [Google Scholar] [CrossRef]
  15. Vignini, A.; Nanetti, L.; Bacchetti, T.; Ferretti, G.; Curatola, G.; Mazzanti, L. Modification induced by homocysteine and low-density lipoprotein on human aortic endothelial cells: An in vitro study. J. Clin. Endocrinol. Metab. 2004, 89, 4558–4561. [Google Scholar] [CrossRef] [Green Version]
  16. Zinellu, A.; Sotgia, S.; Scanu, B.; Pintus, G.; Posadino, A.M.; Cossu, A.; Deiana, L.; Sengupta, S.; Carru, C. S-homocysteinylated LDL apolipoprotein B adversely affects human endothelial cells in vitro. Atherosclerosis 2009, 206, 40–46. [Google Scholar] [CrossRef]
  17. Breilmann, J.; Pons-Kühnemann, J.; Brunner, C.; Richter, M.; Neuhäuser-Berthold, M. Effect of antioxidant vitamins on the plasma homocysteine level in a free-living elderly population. Ann. Nutr. Metab. 2010, 57, 177–182. [Google Scholar] [CrossRef]
  18. Cha, J.; Niedzwiecki, A.; Rath, M. Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice. Am. J. Cardiovasc. Dis. 2015, 5, 53–62. [Google Scholar]
  19. Block, G.; Jensen, C.D.; Dalvi, T.B.; Norkus, E.P.; Hudes, M.; Crawford, P.B.; Holland, N.; Fung, E.B.; Schumacher, L.; Harmatz, P. Vitamin C treatment reduces elevated C-reactive protein. Free Radic. Biol. Med. 2009, 46, 70–77. [Google Scholar] [CrossRef] [Green Version]
  20. Rowe, S.; Carr, A.C. Global Vitamin C Status and Prevalence of Deficiency: A Cause for Concern? Nutrients 2020, 12, 2008. [Google Scholar] [CrossRef]
  21. Bentham, J.; Singh, G.M.; Danaei, G.; Green, R.; Lin, J.K.; Stevens, G.A.; Farzadfar, F.; Bennett, J.E.; di Cesare, M.; Dangour, A.D.; et al. Multi-dimensional characterisation of global food supply from 1961–2013. Nat. Food. 2020, 1, 70–75. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Chen, J.Y.; Cheng, T.-J.; Chang, C.-Y.; Lan, K.-M.; Weng, S.-F.; Sheu, M.-J.; Tseng, S.-F.; Hu, M.-L. Increased incidence of herpes zoster in adult patients with peptic ulcer disease: A population-based cohort study. Int. J. Epidemiol. 2013, 42, 1873–1881. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Wang, L.K.; Hung, K.-C.; Lin, Y.-T.; Chang, Y.-J.; Wu, Z.-F.; Ho, C.-H.; Chen, J.-Y. Age, Gender and Season Are Good Predictors of Vitamin D Status Independent of Body Mass Index in Office Workers in a Subtropical Region. Nutrients 2020, 12, 2719. [Google Scholar] [CrossRef] [PubMed]
  24. Wang, L.K.; Lin, Y.-T.; Hung, K.-C.; Chang, C.-Y.; Wu, Z.-F.; Hu, M.-L.; Chen, J.-Y. Plasma Vitamin C Concentrations Were Negatively Associated with Tingling, Prickling or Pins and Needles Sensation in Patients with Postherpetic Neuralgia. Nutrients 2020, 12, 2384. [Google Scholar] [CrossRef] [PubMed]
  25. Kilpatrick, E.S.; Bloomgarden, Z.T.; Zimmet, P.Z. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes: Response to the International Expert Committee. Diabetes Care 2009, 32, e159. [Google Scholar] [CrossRef] [Green Version]
  26. Lorenzo, C.; Waagenknecht, L.E.; Hanley, A.J.G.; Rewers, M.J.; Karter, A.J.; Haffner, S.M. A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: The Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010, 33, 2104–2109. [Google Scholar] [CrossRef] [Green Version]
  27. Lykkesfeldt, J.; Tveden-Nyborg, P. The Pharmacokinetics of Vitamin C. Nutrients 2019, 11, 2412. [Google Scholar] [CrossRef] [Green Version]
  28. Grunfeld, C.; A Delaney, J.; Wanke, C.; Currier, J.S.; Scherzer, R.; Biggs, M.L.; Tien, P.C.; Shlipak, M.G.; Sidney, S.; Polak, J.F.; et al. Preclinical atherosclerosis due to HIV infection: Carotid intima-medial thickness measurements from the FRAM study. AIDS 2009, 23, 1841–1849. [Google Scholar] [CrossRef]
  29. Agarwal, A.; Prasad, G.V. Post-transplant dyslipidemia: Mechanisms, diagnosis and management. World J. Transplant. 2016, 6, 125–134. [Google Scholar] [CrossRef]
  30. Chatrath, H.; Vuppalanchi, R.; Chalasani, N. Dyslipidemia in patients with nonalcoholic fatty liver disease. Semin. Liver Dis. 2012, 32, 22–29. [Google Scholar] [CrossRef] [Green Version]
  31. Vaziri, N.D. Dyslipidemia of chronic renal failure: The nature, mechanisms, and potential consequences. Am. J. Physiol. Renal. Physiol. 2006, 290, F262–F272. [Google Scholar] [CrossRef] [PubMed]
  32. German Nutrition Society. New Reference Values for Vitamin C Intake. Ann. Nutr. Metab. 2015, 67, 13–20. [Google Scholar] [CrossRef] [PubMed]
  33. Carr, A.C.; Rosengrave, P.C.; Bayer, S.; Chambers, S.; Mehrtens, J.; Shaw, G.M. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit. Care 2017, 21, 300. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Pincemail, J.; Vanbelle, S.; Degrune, F.; Cheramy-Bien, J.; Charlier, C.; Chapelle, J.; Giet, D.; Collette, G.; Albert, A.; Defraigne, J. Lifestyle Behaviours and Plasma Vitamin C and beta-Carotene Levels from the ELAN Population (Liege, Belgium). J. Nutr. Metab. 2011, 2011, 494370. [Google Scholar] [CrossRef] [Green Version]
  35. Crook, J.; Horgas, A.; Yoon, S.-J.; Grundmann, O.; Johnson-Mallard, V. Insufficient Vitamin C Levels among Adults in the United States: Results from the NHANES Surveys, 2003–2006. Nutrients 2021, 13, 3910. [Google Scholar] [CrossRef]
  36. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363, 157–163. [Google Scholar] [CrossRef]
  37. Huang, Y.C.; Ho, C.-C.; Lin, P.-T.; Lee, B.-J.; Lai, C.-H.; Liaw, Y.-P. Optimal cutoff value of high-density lipoprotein cholesterol for predicting coronary artery disease in Taiwanese population. Nutr. Res. 2010, 30, 21–26. [Google Scholar] [CrossRef]
  38. Wald, D.S.; Law, M.; Morris, J.K. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 2002, 325, 1202. [Google Scholar] [CrossRef] [Green Version]
  39. Jacobson, T.A. Lipoprotein(a), cardiovascular disease, and contemporary management. Mayo Clin. Proc. 2013, 88, 1294–1311. [Google Scholar] [CrossRef] [Green Version]
  40. Robitaille, L.; Hoffer, L.J. A simple method for plasma total vitamin C analysis suitable for routine clinical laboratory use. Nutr. J. 2016, 15, 40. [Google Scholar] [CrossRef] [Green Version]
  41. Kim, H.N.; Yoon, S.Y. Comparison of a new enzymatic assay for serum homocysteine on Toshiba TBA-c16000 against an immunoassay on Abbott Architect. Scand. J. Clin. Lab. Invest. 2021, 81, 46–51. [Google Scholar] [CrossRef] [PubMed]
  42. Pieri, M.; Ciotti, M.; Nuccetelli, M.; Perrone, M.A.; Caliò, M.T.; Lia, M.S.; Minieri, M.; Bernardini, S. Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis. Int. Immunopharmacol. 2021, 95, 107512. [Google Scholar] [CrossRef] [PubMed]
  43. Marcovina, S.M.; Albers, J.J. Lipoprotein (a) measurements for clinical application. J. Lipid. Res. 2016, 57, 526–537. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Paalanen, L.; Prättälä, R.; Alfthan, G.; Salminen, I.; Laatikainen, T. Vegetable and fruit consumption, education and plasma vitamin C concentration in Russian and Finnish Karelia, 1992–2002. Public Health Nutr. 2014, 17, 2278–2286. [Google Scholar] [CrossRef] [Green Version]
  45. Pearson, J.F.; Pullar, J.M.; Wilson, R.; Spittlehouse, J.K.; Vissers, M.C.M.; Skidmore, P.M.L.; Willis, J.; Cameron, V.A.; Carr, A.C. Vitamin C Status Correlates with Markers of Metabolic and Cognitive Health in 50-Year-Olds: Findings of the CHALICE Cohort Study. Nutrients 2017, 9, 831. [Google Scholar] [CrossRef] [PubMed]
  46. Saito, K.; Yokoyama, T.; Yoshida, H.; Kim, H.; Shimada, H.; Yoshida, Y.; Iwasa, H.; Shimizu, Y.; Kondo, Y.; Handa, S.; et al. A significant relationship between plasma vitamin C concentration and physical performance among Japanese elderly women. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67, 295–301. [Google Scholar] [CrossRef] [PubMed]
  47. Pan, W.H.; Yeh, N.-H.; Yang, R.-Y.; Lin, W.-H.; Wu, W.-C.; Yeh, W.-T.; Sung, M.-K.; Lee, H.-S.; Chang, S.-J.; Huang, C.-J.; et al. Vegetable, fruit, and phytonutrient consumption patterns in Taiwan. J. Food Drug Anal. 2018, 26, 145–153. [Google Scholar] [CrossRef] [Green Version]
  48. Schleicher, R.L.; Carroll, M.D.; Ford, E.S.; A Lacher, D. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003–2004 National Health and Nutrition Examination Survey (NHANES). Am. J. Clin. Nutr. 2009, 90, 1252–1263. [Google Scholar] [CrossRef]
  49. Prattala, R.; Paalanen, L.; Grinberga, D.; Helasoja, V.; Kasmel, A.; Petkeviciene, J. Gender differences in the consumption of meat, fruit and vegetables are similar in Finland and the Baltic countries. Eur. J. Public Health 2007, 17, 520–525. [Google Scholar] [CrossRef]
  50. Jungert, A.; Neuhauser-Berthold, M. The lower vitamin C plasma concentrations in elderly men compared with elderly women can partly be attributed to a volumetric dilution effect due to differences in fat-free mass. Br. J. Nutr. 2015, 113, 859–864. [Google Scholar] [CrossRef] [Green Version]
  51. Frankenfeld, C.L.; Lampe, J.W.; Shannon, J.; Gao, D.L.; Li, W.; Ray, R.M.; Chen, C.; King, I.B.; Thomas, D.B. Fruit and vegetable intakes in relation to plasma nutrient concentrations in women in Shanghai, China. Public Health Nutr. 2012, 15, 167–175. [Google Scholar] [CrossRef] [PubMed]
  52. Hooper, P.L.; Hooper, E.M.; Hunt, W.C.; Garry, P.J.; Goodwin, J.S. Vitamins, lipids and lipoproteins in a healthy elderly population. Int. J. Vitaminol. Nutr. Res. 1983, 53, 412–419. [Google Scholar] [PubMed]
  53. McRae, M.P. Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: A meta-analysis of 13 randomized controlled trials. J. Chiropr. Med. 2008, 7, 48–58. [Google Scholar] [CrossRef] [Green Version]
  54. Kubota, Y.; Moriyama, Y.; Yamagishi, K.; Tanigawa, T.; Noda, H.; Yokota, K.; Harada, M.; Inagawa, M.; Oshima, M.; Sato, S.; et al. Serum vitamin C concentration and hs-CRP level in middle-aged Japanese men and women. Atherosclerosis 2010, 208, 496–500. [Google Scholar] [CrossRef] [PubMed]
  55. Wang, S.M.; Fan, J.-H.; Taylor, P.R.; Lam, T.K.; Dawsey, S.M.; Qiao, Y.-L.; Abnet, C.C. Association of plasma vitamin C concentration to total and cause-specific mortality: A 16-year prospective study in China. J. Epidemiol. Community Health 2018, 72, 1076–1082. [Google Scholar] [CrossRef] [PubMed]
  56. Shi, L.; Niedzwiecki, A.; Rath, M. Age and Dietary Vitamin C Intake Affect Brain Physiology in Genetically Modified Mice Expressing Human Lipoprotein(A) and Unable to Synthesize Vitamin C. Curr. Aging. Sci. 2021, 14, 223–234. [Google Scholar] [CrossRef]
  57. Bostom, A.G.; Hume, A.L.; Eaton, C.; Laurino, J.P.; Yanek, L.R.; Regan, M.S.; McQuade, W.H.; Craig, W.Y.; Perrone, G.; Jacques, P.F. The effect of high-dose ascorbate supplementation on plasma lipoprotein(a) levels in patients with premature coronary heart disease. Pharmacotherapy 1995, 15, 458–464. [Google Scholar]
  58. Dehghan, M.; Akhtar-Danesh, N.; McMillan, C.R.; Thabane, L. Is plasma vitamin C an appropriate biomarker of vitamin C intake? A systematic review and meta-analysis. Nutr. J. 2007, 6, 41. [Google Scholar] [CrossRef] [Green Version]
Nutrients 14 01108 g001 550
Figure 1. (a) Distribution of plasma vitamin C concentrations among all adults in a subtropical region; (b) Distribution of plasma vitamin C concentrations in female and male adults in a subtropical region.
Figure 1. (a) Distribution of plasma vitamin C concentrations among all adults in a subtropical region; (b) Distribution of plasma vitamin C concentrations in female and male adults in a subtropical region.
Nutrients 14 01108 g001
Table
Table 1. Demographic and anthropometric characteristics of the study population in a subtropical region.
Table 1. Demographic and anthropometric characteristics of the study population in a subtropical region.
Vitamin C Status
Total (n = 3899)
Mean (SD)		Sufficient (n = 2379, 61%)
(≥50 µmol/L, ≥8.9 mg/L)		Insufficient (n = 1520, 39%)
(<50 µmol/L, ≤8.8 mg/L)		p
Age, mean (SD), years48.59 (11.92)49.2 (11.9)47.6 (11.8)<0.001
BMI, mean (SD)24.27 (3.48)23.54 (3.54)24.90 (3.86)<0.001
Gender, mean (SD), mg/L n (%)n (%)<0.001
 Male9.04 (3.09)1143 (48.0%)1044 (68.7%)
 Female10.78 (3.14)1236 (52.0%)476 (31.3%)
Vitamin C status in age groups, mean (SD), mg/L n (%)n (%)0.001
 20–399.47 (3.35)531 (22.3%)419 (27.6%)
 40–599.80 (3.16)1357 (57.0%)831 (54.7%)
 ≥6010.2 (3.26)491 (20.7%)270 (17.7%)
Vitamin C status in seasons, mean (SD), mg/L (* Seasonal fruits and vitamin C amount per 100 g) n (%)n (%)<0.001
 Winter (* oranges 41.2 mg; apples 2.9 mg)9.44 (3.07)679 (58.7%)478 (41.3%)
 Spring (* pineapples 12.0 mg; bananas 10.7 mg)9.48 (2.97)428 (56.2%)333 (43.8%)
 Summer (* lychees 52.3 mg; mangoes 22.7 mg; pears 4.6 mg; grapes 3.8 mg)10.04 (3.28)506 (62.7%)301 (37.3%)
 Autumn (* guavas 137.9 mg; papayas 58.3 mg; pomelos 54.5 mg; pitayas 5.3–6.3 mg)10.19 (3.42)766 (65.3%)408 (34.7%)
Vitamin C status in BMI groups, mean (SD), mg/L <0.001
 Obesity (≥27.5)8.67 (3.2)11.41 (2.19)6.42 (2.00)
 Overweight (23–27.4)9.56 (3.07)11.55 (2.11)6.73 (1.71)
 Normal (<23)10.5 (3.23)12.07 (2.28)6.86 (1.87)
SD—standard deviation; BMI—body mass index; n—number. Student t-test was used for the differences in continuous data between groups; chi-square test for the differences in categorical variables among groups. * Seasonal fruits and vitamin C amount per 100 g.
Table
Table 2. Predictors for insufficient vitamin C levels (<50 µmol/L, ≤8.8 mg/L) among all subjects.
Table 2. Predictors for insufficient vitamin C levels (<50 µmol/L, ≤8.8 mg/L) among all subjects.
Vitamin C StatusSufficient, n (%)Insufficient, n (%)Crude OR (95% CI)pAOR (95% CI)p
All2379 (61.0)1520 (39.0)
Gender
 Male1143 (52.3)1044 (47.7)2.37 (2.07–2.71)<0.0012.14 (1.85–2.48)<0.001
 Female1236 (72.2)476 (27.8)1.0 1.0
Age groups
 20–39531 (55.9)419 (44.1)1.44 (1.18–1.75)<0.0011.63 (1.33–1.99)<0.001
 40–591357 (62.0)831 (38.0)1.11 (0.94–1.32)0.2201.11 (0.93–1.33)0.237
 ≥60491 (64.5)270 (35.5)1.0 1.0
Season
 Winter/Spring1107 (57.7)811 (42.3)1.31 (1.16–1.50)<0.0011.37 (1.20–1.57)<0.001
 Summer/Autumn1272 (64.2)709 (35.8)1.0 1.0
BMI groups
 Obesity (≥27.5)289 (45.2)351 (54.8)2.78 (2.30–3.35)<0.0012.13 (1.74–2.60)<0.001
 Overweight (23–27.4)961 (58.7)675 (41.3)1.61 (1.39–1.86)<0.0011.30 (1.12–1.52)<0.001
 Normal (<23)1129 (69.6)494 (30.4)1.0 1.0
OR—odds ratio; BMI—body mass index; AOR—adjusted odds ratio. AOR—Adjusted Gender, Age groups, Season and BMI groups. Only variables with p < 0.10 in univariate logistic analyses were entered into a multivariate logistic regression.
Table
Table 3. (a) Predictors for insufficient vitamin C levels (<50 µmol/L, ≤8.8 mg/L) among female adults. (b) Predictors for insufficient vitamin C levels (<50 µmol/L, ≤8.8 mg/L) among male adults.
Table 3. (a) Predictors for insufficient vitamin C levels (<50 µmol/L, ≤8.8 mg/L) among female adults. (b) Predictors for insufficient vitamin C levels (<50 µmol/L, ≤8.8 mg/L) among male adults.
(a)
Vitamin C StatusSufficient, n (%)Insufficient, n (%)Crude OR (95% CI)pAOR (95% CI)p
Female1236 (72.2)476 (27.8)
Age group
 20–39313 (63.2)182 (37.8)1.94 (1.41–2.67)<0.0012.21 (1.59–3.06)<0.001
 40–59676 (75.4)220 (24.6)1.09 (0.80–1.47)0.5901.17 (0.86–1.59)0.319
 ≥60247 (76.9)74 (23.1)1.0 1.0
Season
 Winter + Spring605 (68.6)276 (32.4)1.44 (1.16–1.78)<0.0011.47 (1.18–1.82)<0.001
 Summer + Autumn631 (75.9)200 (24.1)1.0 1.0
BMI groups
 Obesity (≥27.5)80 (53.6)69 (46.4)2.65 (1.87–3.77)<0.0012.96 (2.07–4.24)0.005
 Overweight (23–27.4)347 (70.6)144 (29.4)1.28 (1.01–1.62)<0.0011.42 (1.11–1.81)<0.001
 Normal (<23)809 (75.4)263 (24.6)1.0 1.0
(b)
Vitamin C StatusSufficient, n (%)Insufficient, n (%)Crude OR (95% CI)pAOR (95% CI)p
Male1143 (52.3)1044 (47.7)
Age group
 20–39218 (47.9)237 (52.1)1.35 (1.04–1.76)0.0241.31 (1.01–1.71)0.048
 40–59681 (52.4)611 (47.6)1.12 (0.90–1.39)0.3191.10 (0.88–1.37)0.411
 ≥60244 (55.4)196 (44.6)1.0 1.0
Season
 Winter + Spring502 (48.4)535 (51.6)1.34 (1.13–1.59)<0.0011.33 (1.12–1.57)0.001
 Summer + Autumn641 (55.7)509 (44.3)1.0 1.0
BMI groups
 Obesity (≥27.5)209 (42.5)282 (57.5)1.87 (1.46–2.39)<0.0011.85 (1.44–2.37)<0.001
 Overweight (23–27.4)614 (53.6)531 (46.4)1.20 (0.98–1.47)0.0851.21 (0.98–1.48)0.073
 Normal (<23)320 (58.0)231 (42.0)1.0 1.0
OR—odds ratio; BMI—body mass index; AOR—adjusted OR. AOR—Adjusted Gender, Age groups, Season and BMI groups. Only variables with p < 0.10 in univariate logistic analyses were entered into a multivariate logistic regression.
Table
Table 4. Lipid-related and lipid-independent risk factors for cardiovascular diseases in subjects with sufficient and insufficient vitamin C.
Table 4. Lipid-related and lipid-independent risk factors for cardiovascular diseases in subjects with sufficient and insufficient vitamin C.
Vitamin C Status
Risk Factors for Cardiovascular DiseasesSufficient (n = 2379, 61%)
Mean (SD)		Insufficient (n = 1520, 39%)
Mean (SD)		p
Lipid-related marker
 Triglycerides, n (%) <0.001
  ≤150 mg/dL1886 (79.3)1075 (71.2)
  >150493 (20.7)435 (28.8)
 Total cholesterol, n (%) 0.613
  ≤200 mg/dL1317 (55.4)854 (56.2)
  >2001062 (44.6)666 (43.8)
 HDL-C, n (%) <0.001
  ≥46 mg/dL1493 (62.7)717 (47.2)
  <46886 (37.3)803 (52.8)
 LDL-C, n (%) 0.646
  <100 mg/dL495 (20.8)307 (20.2)
  ≥1001884 (79.2)1213 (79.8)
Lipid-independent marker
 Lipoprotein(a), n (%) 0.761
  <30 mg/dL1908 (80.2)1213 (79.8)
  ≥30471 (19.8)307 (20.2)
 Homocysteine, n (%) <0.001
  ≤10 umol/L1789 (75.2)763 (50.2)
  >10590 (24.8)757 (49.8)
 hs-CRP, n (%) <0.001
  <1.0 mg/L1387 (58.3)555 (36.5)
  ≥1.0992 (41.7)965 (63.5)
HDL-C—high-density lipoprotein cholesterol; LDL-C—low-density lipoprotein cholesterol; hs-CRP—high-sensitivity C-reactive protein. Chi-square test for the differences in categorical variables between groups.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lin, Y.-T.; Wang, L.-K.; Hung, K.-C.; Chang, C.-Y.; Wu, L.-C.; Ho, C.-H.; Chen, J.-Y. Prevalence and Predictors of Insufficient Plasma Vitamin C in a Subtropical Region and Its Associations with Risk Factors of Cardiovascular Diseases: A Retrospective Cross-Sectional Study. Nutrients 2022, 14, 1108. https://0-doi-org.brum.beds.ac.uk/10.3390/nu14051108

AMA Style

Lin Y-T, Wang L-K, Hung K-C, Chang C-Y, Wu L-C, Ho C-H, Chen J-Y. Prevalence and Predictors of Insufficient Plasma Vitamin C in a Subtropical Region and Its Associations with Risk Factors of Cardiovascular Diseases: A Retrospective Cross-Sectional Study. Nutrients. 2022; 14(5):1108. https://0-doi-org.brum.beds.ac.uk/10.3390/nu14051108

Chicago/Turabian Style

Lin, Yao-Tsung, Li-Kai Wang, Kuo-Chuan Hung, Chia-Yu Chang, Li-Ching Wu, Chung-Han Ho, and Jen-Yin Chen. 2022. "Prevalence and Predictors of Insufficient Plasma Vitamin C in a Subtropical Region and Its Associations with Risk Factors of Cardiovascular Diseases: A Retrospective Cross-Sectional Study" Nutrients 14, no. 5: 1108. https://0-doi-org.brum.beds.ac.uk/10.3390/nu14051108

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop